Child & Adolescent Psychiatry Research

Current Study

Major Depression Disorder in Adolescents
Status:  Open for participation

Research Contact Person: Martha Barron | tel: (520) 626-7325 or email
Principal Investigator:  Karen Weihs, MD
The purpose of this study is to evaluate Levomilnacipran ER relative to placebo.  The eligibility criteria are for adolescents between 12-17 years of age, inclusive, diagnosed with major depressive disorder.  The duration of the study is 9 weeks. For additional infomation and exclusion criteria, please contact Martha Barron at (520) 626-7325.